StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Panacea Life Sciences's price to sales ratio was 0.5× on Oct 19, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.2× to 4.4×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.5×+0.1
2025Dec 31, 20250.3×+0.2
2024Dec 31, 20240.2×−1.3
2023Dec 29, 20231.5×+1.0
2022Dec 30, 20220.5×–

More Panacea Life Sciences figures

See a number that looks wrong?